Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ resapp health limited

Totally ignorant and wrong comments are the typical response for...

First 2920 Last

Share
Profile

Follow
nippy

11,124 Posts.

698

11/04/22

06:54

Post #: 60772534
Share

Originally posted by Rachel_E: ↑

The Australian/ news.com sites have an article today: While only a handful, comments so far (see end) indicated a lot of scepticism.

ResApp Health is trialling a smartphone app to diagnose Covid through sound of coughing
A Brisbane digital health start-up wants to shake-up the way we test for Covid-19 with the trial of a smartphone app which will diagnose the disease through the sound of your cough.
CITY BEAT CHRIS HERDE
less than 2 min readApril 10, 2022 - 4:42PM
The Australian Business Network
7 comments

ResApp Health is trialling a smartphone application that can diagnose Covid-19.

A Brisbane digital health start-up is on the way to the commercialisation of a smartphone application which will use the sound of your coughing to diagnose Covid-19.

ASX-listed ResApp Health is preparing for talks with regulators after positive results on the technology for screening before the use of a rapid antigen (RAT) or PCR test.

Dr Tony Keating, who founded the company in 2015 with Brian Leedman, says trials found the app could detect Covid in 92 per cent of people with the infection through the use of cough audio and patient-reported symptoms.

“The Covid tests are still in the early trial stages but we have had great results,” he says.

“Basically the way we’ve designed the test is that of it says No and you don’t have Covid, you don’t have to do a RAT or a PCR test but if it says YES then you go down the normal path of testing.”

A Covid test that only requires a smartphone would significantly reduce the number of RAT or PCR tests required, improving availability, reducing costs, and reducing environmental impact.ResApp Health managing director Dr Tony Keating.ResApp Health managing director Dr Tony Keating.

A smartphone-based test also has the ability to improve security and reporting of results to employees and other group by using biometric identification such as facial recognition.

The technology is based on research by University of Queensland Associate Professor Udantha Abeyratne whose work was funded through the Bill and Melinda Gates Foundation.

That work led to ResApp Health winning regulatory approval and then the commercialisation of the initial research which enabled the detection of asthma, pneumonia and other respiratory conditions by coughing through the telehealth service used by doctors working remotely.

When the pandemic hit the company started working on new algorithms for the technology to diagnose Covid through a smartphone.

Keating says it’s too early to say when the smartphone app will be available.“We’re talking to pharmaceutical companies, tech companies, government and any number of big organisations who can help us bring this technology to everyone’s home,” he says.

Comments so far:
Janice 8 hours agoWhat a freaking joke are you serious!
Adam 9 hours agoAre we for real? I guess with the amount of false positives the RAT's are giving, it couldnt be much worse!
Skot 9 hours agoI had no cough until 2 days after my positive RAT test. Too late for this app to diagnose me.
Jay 10 hours agoProbably more accurate than those rats tests..Mex 10 hours agoThis is the most ridiculous idea I’ve ever heard
olivia 11 hours agoWhat about the many people who don’t get a cough or in fact any symptoms.
Valerie 11 hours agoWhat a joke!

Expand

Totally ignorant and wrong comments are the typical response for anything new eg bacteria causing stomache ulcers got outright derision at first from the medical fraternity - and a few years later a Nobel Prize was given...

Same sort of response given to laser surgery for eyes and to horseless carriages....

RAP Price at posting: 9.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

AI stocks: What to expect in 2024-25

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

There are more pages in this discussion • 477 more messages in this thread...

First 2920 Last

Add RAP (ASX) to my watchlist